TERRI POWELL: Open Payments
NPI 1235840737 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 52 payments from 14 companies in 2025. Trend: 2023 $182 · 2024 $795 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $255 |
| Novo Nordisk Inc | 12 | $206 |
| Viatris Specialty LLC | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Lilly USA, LLC | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: VRAYLAR, Ozempic, QULIPTA, YUPELRI, AIRSUPRA, Auvelity, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
